What is Bioventus's interest income (expense), nonoperating?

Bioventus (BVS) reported interest income (expense), nonoperating of -$4.33M in Q1 2026.

How has Bioventus's interest income (expense), nonoperating changed year-over-year?

Bioventus's interest income (expense), nonoperating increased by 42.4% year-over-year, from -$7.51M to -$4.33M.

What is the long-term trend for Bioventus's interest income (expense), nonoperating?

Over 4 years (2021 to 2025), Bioventus's interest income (expense), nonoperating has grown at a 120.9% compound annual growth rate (CAGR), from -$1.11M to -$26.49M.

Bioventus BVS Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Globus MedicalGMED

——

Envista Holdings CorporationNVST

——

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's interest income (expense), nonoperating?: Bioventus (BVS) reported interest income (expense), nonoperating of -$4.33M in Q1 2026.
How has Bioventus's interest income (expense), nonoperating changed year-over-year?: Bioventus's interest income (expense), nonoperating increased by 42.4% year-over-year, from -$7.51M to -$4.33M.
What is the long-term trend for Bioventus's interest income (expense), nonoperating?: Over 4 years (2021 to 2025), Bioventus's interest income (expense), nonoperating has grown at a 120.9% compound annual growth rate (CAGR), from -$1.11M to -$26.49M.